Precision Optics (POCI) Stock Price, News & Analysis

Company Overview

Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. The company also provides components and assemblies for industrial and military use. It markets its products to medical device companies. The company was incorporated in 1982 and is based in Gardner, Massachusetts.

Key Stats

• Today's Range: $4.50 to $4.95
• 50-Day Range: $3.90 to $4.70
• 52-Week Range: $3.55 to $6.04
• Volume: 13,772 shs
• Average Volume: 26,730 shs
• Market Capitalization: $36.10 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

Precision Optics Stock Analysis - MarketRank™

Precision Optics scored higher than 8% of companies evaluated by MarketBeat, and ranked 826th out of 856 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.5 / 5
• Analyst Rating: Sell

Consensus Rating

Precision Optics has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Precision Optics has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Precision Optics is -5.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Precision Optics is -5.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Precision Optics has a P/B Ratio of 2.93. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.32% of the float of Precision Optics has been sold short.

Short Interest Ratio / Days to Cover

Precision Optics has a short interest ratio ("days to cover") of 0.49, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Precision Optics has recently decreased by 20.20%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Precision Optics does not currently pay a dividend.

Dividend Growth

Precision Optics does not have a long track record of dividend growth.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Precision Optics this week, compared to 1 article on an average week.

MarketBeat Follows

1 people have added Precision Optics to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Precision Optics insiders have not sold or bought any company stock.

Percentage Held by Insiders

14.40% of the stock of Precision Optics is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

13.71% of the stock of Precision Optics is held by institutions.

POCI Stock Analysis - Frequently Asked Questions

How have POCI shares performed this year?

Precision Optics' stock was trading at $4.18 at the start of the year. Since then, POCI shares have increased by 12.1% and is now trading at $4.6850.

How were Precision Optics' earnings last quarter?

Precision Optics Corp. (NASDAQ:POCI) announced its quarterly earnings results on Tuesday, February, 17th. The company reported ($0.23) earnings per share for the quarter. The business had revenue of $7.37 million for the quarter. Precision Optics had a negative trailing twelve-month return on equity of 60.56% and a negative net margin of 28.33%.
Read the conference call transcript.

How do I buy shares of Precision Optics?

Shares of POCI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Precision Optics own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Precision Optics investors own include Arch Capital Group (ACGL), Adobe (ADBE), Analog Devices (ADI), Alnylam Pharmaceuticals (ALNY), Amgen (AMGN), Baidu (BIDU).

Company Calendar

• Last Earnings: 2/17/2026
• Today: 5/06/2026
• Next Earnings (Estimated): 5/14/2026
• Fiscal Year End: 6/30/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:POCI
• CIK: 867840
• Web: www.poci.com
• Phone: (978) 630-1800
• Fax: 978-630-1487
• Employees: 80
• Year Founded: 1982

Profitability

• EPS (Trailing Twelve Months): ($0.92)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$5.78 million
• Net Margins: -28.33%
• Pretax Margin: -28.32%
• Return on Equity: -60.56%
• Return on Assets: -32.67%

Debt

• Debt-to-Equity Ratio: 0.11
• Current Ratio: 1.05
• Quick Ratio: 0.62

Sales & Book Value

• Annual Sales: $19.09 million
• Price / Sales: 1.90
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $1.60 per share
• Price / Book: 2.93

Miscellaneous

• Outstanding Shares: 7,730,000
• Free Float: 6,620,000
• Market Cap: $36.22 million
• Optionable: Not Optionable
• Beta: 0.23